This 2018 case report presents the clinical course of a patient with Stage IV renal cell carcinoma who achieved long-term survival following an integrative treatment protocol initiated after failure of conventional therapies. The regimen included intravenous α-lipoic acid, vitamin C, low-dose naltrexone (LDN), hydroxycitrate, and comprehensive lifestyle changes. The treatment
